Professional summary

Dr Desai’s was the Director of Rheumatology and Oncology at SmithKline Beecham and Global Clinical Director at Aventis Pharmaceuticals before becoming the Vice President of Pre-Clinical and Clinical Research at Neose Technologies, and Chief Medical Officer of Biotherapharma. He founded International Medical Consultants and IMC Radiology in 2006. He co-founded Omega Solutions in 2011 and was successful in exiting for a 20x profit in 2016.

Dr Desai is also an active writer for investment websites (previously for, and presently with and is a published author (Germs of War). He is a speaker at various medical and business conferences and was a medical advisor to ABC News on bioterrorism

Specialties: Assessment

Engagement overview

Assessment of overall company strategy and pre-clinical/clinical plans. Due diligence and evaluation of in-licensing compounds. Planning and executing studies in pre-clinical pharmacology and toxicology,.  Planning and executing studies in clinical research including writing clinical protocols, clinical development plans, medical monitoring, writing ISS/ISE. Regulatory guidance, filing IND/NDA/BLA, marketing support, publishing in journals. Therapeutic areas include immunology, rheumatology, pulmonary, metabolism, neurology, oncology, vaccines, ID.


• Wyeth
• Astra Zeneca
• US Government DoD
• Novartis
• Medimmune
• Curry Pharmaceuticals
• Pinnacle Therapeutics
• Metastatix
• Azenvan Pharmaceuticals
• Sirtex Technologies
• Oncoceutics

  • linkedin logo
Areas of expertise